Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2006; 12(9): 1356-1361
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1356
Table 1 Expression of PI, AI, Fas/ FasL compared to operation procedure, early or advanced tumor, T, N, M and UICC stages
PI AIFasFasLPD-ECGF
(%) (%)+ -+ -+ -
Way of resection
radical46.31±15.30 12.13±9.6526 1629 1319 23
Palliation50.74±21.27 9.40±8.352 1010 27 5
P2 Value0.654 0.7917.6510.9490.641
P Value0.422 0.3780.0060.330.423
Early cancer
Yes45.29±12.34 14.54±12.387 26 33 6
No47.70±17.51 10.92±8.7021 2433 1223 22
F2 Value0.154 1.1232.9080.1660.949
P Value0.697 0.2940.0880.6840.33
Invasion depth
T1-246.65±15.76 11.96±9.8120 819 912 16
T3-447.99±17.92 11.06±9.048 1820 614 12
F2 Value0.086 0.1218.9270.5520.652
P Value0.770 0.7290.0030.4570.419
Lymphonode
N050.37±16.34 10.51±9.8913 514 49 9
N1-445.76±16.87 12.03±9.2015 2125 1117 19
F2 value0.917 0.3124.4880.4150.037
P value0.343 0.5790.0340.5190.847
Metastasis
M046.73±15.79 11.51±9.1026 1933 1222 23
M150.10±21.5 11.60±11.247 26 34 5
F2 value0.301 0.0013.7980.1660.059
P value0.585 0.9800.0510.6840.808
UICC stage
I50.42±16.84 10.98±9.9913 413 49 8
II42.69±13.24 11.78±10.655 46 32 7
III46.03±16.2 12.73±10.107 911 57 9
IV48.01±20.18 10.52±7.253 99 38 4
F2 value0.452 0.1488.0630.4344.352
P value0.717 0.9310.0450.9330.226
Table 2 Influence of preoperative chemotherapy on expression of Fas/FasL, PD-ECGF and AI, PI
Group NFasFasLPIAIPD-ECGF + -
+ -+ -(%)(%)
5’-DFUR 1812 69 940.51 ± 12.6214.39 ± 9.494 14
CF+5-FU   167 913 341.12 ± 15.2614.11 ± 9.689 7
Control 209 1117 358.33 ± 15.696.88 ± 7.3713 7
X2/F value2.3796.7089.0834.4097.542
P value0.3040.03500.0170.023